Biomarkers of Response to Mepolizumab Treatment in Patients With Nasal Polyps With or Without Bronchial Asthma

NCT05708300 · clinicaltrials.gov ↗

RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps
Asthma

Interventions

DRUG: Mepolizumab 100 MG [Nucala]

Sponsor

Aristotle University Of Thessaloniki

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]